Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Liposomes
Reexamination Certificate
2006-08-15
2006-08-15
Ketter, James (Department: 1636)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Liposomes
C424S009100, C424S009200
Reexamination Certificate
active
07090864
ABSTRACT:
Liposomes containing therapeutic genes are conjugated to multiple targeting agents to provide transport of the encapsulated gene across the blood-retinal barrier and the plasma membrane of ocular cells. Once across the blood-retinal barrier and ocular cell membrane, the encapsulated gene expresses the encoded therapeutic agent within the ocular cells to provide diagnosis and/or treatment of disease.
REFERENCES:
patent: 5154924 (1992-10-01), Friden
patent: 5182107 (1993-01-01), Friden
patent: 5672683 (1997-09-01), Friden et al.
patent: 5833988 (1998-11-01), Friden
patent: 5977307 (1999-11-01), Friden et al.
patent: 6372250 (2002-04-01), Pardridge
Check, E. Cancer fears cast doubts on future of gene therapy. Nature 421:678, 2003.
Verma et al. Gene therapy-promises, problems and prospects. Nature 389: 239-242, 1997.
Monnard, P.A., Oberholzer, T., and Luisi, P. (1997)Biochem. Biophys. Acta1329, 39-50.
Huwyler, J., Wu, D., and Padridge, W.M. (1996)Proc. Natl. Acad. Sci. USA93, 14164-14169.
Bennett, J., Maguire, A.M., Cideciyan, A.V., et al. (1999)Proc. Natl. Acad. Sci. USA, 96, 9920-9925.
Lau, D., McGee, L.H., Zhou, S., Rendahl, K.G., Manning, W.C., Escobedo, J.A., and Flannery, J.G. (2000)Invest. Ophthalmol. Vis. Sci., 41, 3622-3633.
Stallwood, Y., Fisher, K.D., Gallimore, P.H., and Mautner, V. (2000)Gene Therapy, 7, 637-643.
Smith, J.G., Raper, S.E., Wheeldon, E.B., Hackney, D., Judy, K., Wilson, J.M., and Eck, S.L. (1997)Human Gene Therapy, 8, 943-954.
Dewey, R.A., Morrissey, G., Cowsill, C.M., et al. (1999)Nature Medicine, 5, 1256-1263.
McMenamin, M.M., Byrnes, A.P., Charlton, H.M., Coffin, R.S., Latchman, D.S., and Wood, M.J.A. (1998)Neuroscience, 83, 1225-1237.
Herrlinger, U., Kramm, C.M., Aboody-Guterman, K.S., et al: (1998)Gene Therapy, 5, 809-819.
Driesse, M.J., Vincent, A.J.P.E., Sillevis Smith, P.A.E., et al, (1998)Gene Therapy, 5, 1122-1129.
Byrnes, A.P., Rusby, J.E., Wood, M.J.A., and Charlton, H.M. (1995)Neuroscience, 66, 1015-1024.
Driesse, M.J., Esandi, M.C., Kros, J.M., et al. (2000)Gene Therapy, 7, 1401-1409.
Kramm, C.M. Rainov, N.G., Sena-Esteves, M., Chase, M., Pechan, P.A., Chiocca, E.A., and Breakefield, X.O. (1996)Human Gene Therapy, 7, 291-300.
Shastry, B.S. (2000)IUBMB Life, 49, 479-484.
Shi, N., Zhang, Y., Boado, R.J., Zhu, C., and Pardridge, W.M. (2001)Proc. Natl. Acad. Sci. USA, 98, 12754-12759.
Sugasawa, K., Deguchi, J., Okami, T., Yamamoto, A., Omori, K., Uyama, M., and Tashiro, Y. (1994)Cell. Struct. Funct., 19, 21-28.
Baudouin, C., Brignole, F., Fredj-Reygrobellet, D., Negre, F., Bayle, J., Gastaud, P. (1992)Invest. Ophthalmol. Vis. Sci., 33, 2822-2829.
Yefimova, M.G., Jeanny, J., Guillonneau, X., Keller, N., Nguyen-Legros, J., Sergeant,C., Guillou, F., Courtois, Y. (2000)Invest. Ophthalmol. Vis. Sci., 41, 2343-2351.
Brenner M., Kisseberth W.C.,.Su Y., Besnard F., Messing A. (1994)J Neurosci.14, 1030-1037.
Segovia J., Vergara P., Brenner M. (1998)Neurosci Lett.242, 172-176.
Kissel K., Hamm S., Schulz M., Vecchi A., Garlanda C., Engelhardt B. (1998)Histochem Cell Biol.110, 63-72.
MacKenzie D., Arendt A., Hargrave P., McDowell J.H., Molday R.S. (1984)Biochem.23, 6544-6549.
Shi N., Pardridge W.M. (2000)Proc Natl Acad Sci USA97, 7567-7572.
Miyoshi H., Takahashi M., Gage F.H., Verma I.M. (1997)Proc Natl Acad Sci USA.94, 10319-10323.
Holash J.A., Stewart P.A. (1993)Brain Res.629, 218-224.
Davis A.A., Hunt R.C. (1993)J Cell Physiol.156, 280-285.
Tan P.H., King W.J., Chen D., et al. (2001)Transplantation.71, 552-560.
Zhuo L., Sun B., Zhang C.L., Fine A., Chiu S.Y., Messing A. (1997)Dev Biol.187, 36-42.
Shi N., Boado R.J., Pardridge W.M. (2001)Pharm Res.18, 1091-1095.
Gollin Michael A.
Hobbs Ann S.
Ketter James
Lambertson David A.
The Regents of the University of California
LandOfFree
Non-invasive gene targeting to ocular cells does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Non-invasive gene targeting to ocular cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Non-invasive gene targeting to ocular cells will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3714400